Opthea
BioTech/Drugs - South Yarra, VIC, AU
Opthea Details
Opthea is a clinical stage biopharmaceutical company committed to developing innovative therapies to help improve visual function in patients suffering with retinal diseases. Our first in class novel therapeutic called OPT-302, is a VEGF-C/D ‘trap', to be used in combination with existing standard of care anti-VEGF-A therapies to improve vision in patients, many of whom respond sub-optimally or become refractory to existing treatments. Millions of people around the world suffer from impaired vision as a result of diabetes and old age. Our mission is to improve vision leading to a better quality of life. Enquiries can be directed to: info@opthea.com
Opthea Technologies
Email Providers
Outlook
CMS
WordPress.org
Tag Management
Google Tag Manager
Hosting
Amazon AWS
Online Video Platforms
Vimeo
Other
Mobile Friendly